vTv Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 148.5 | – | |
| 3,395.5 | 2,935.5 | 8,885.5 | 407.3 | 605.8 | 199.9 | 17.1 | 3.2 | 1.2 | 3.8 | 3.4 | 3.7 | 7.1 | 23.3 | 44.6 | 4,823.8 | 3,946.8 | 14.1 | 21.4 | 18.2 | 8.8 | 16.7 | 9.6 | 10.5 | 38.7 | 26.6 | 3,666.8 | 3,349.9 | 2,172.9 | – | 97.3 | 114.4 | 74.9 | 78.3 | 6,699.0 | 5,812.1 | 11,088.8 | – | 9.1 | 12.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.7 | 6.9 | 4.9 | 6.5 | 14.4 | 35.8 | 2.7 | 5.2 | 3.7 | 5.9 | |
| 3,346.2 | 2,884.9 | 8,832.4 | 294.0 | 593.6 | 226.8 | 22.8 | 6.9 | 2.9 | 5.0 | 4.2 | 4.6 | 8.0 | 25.0 | 46.8 | 4,749.7 | 3,978.2 | 13.3 | 20.3 | 16.8 | 7.0 | 13.4 | 7.2 | 7.0 | 31.5 | 20.8 | 2,632.9 | 2,658.9 | 1,750.7 | – | 45.2 | 68.6 | 33.1 | 42.3 | 4,879.4 | 4,291.9 | 5,315.6 | – | – | – | |
| -1.6% | -2.6% | -1.9% | -104.7% | -86.1% | -76.7% | -90.9% | -217.9% | -285.6% | -56.2% | -69.2% | -58.8% | -44.8% | -36.6% | -28.7% | -20.7% | -25.6% | -19.9% | -11.2% | -12.6% | -15.5% | -27.6% | -29.3% | -17.9% | -19.0% | -28.4% | -29.4% | -43.6% | -58.9% | -79.6% | -21.8% | -19.2% | -31.5% | -31.8% | -20.8% | -22.3% | -11.0% | -7.5% | -3.1% | -3.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -5,203.5% | -7,115.8% | -15,654.5% | -35,905.9% | -42,265.6% | -13,522.0% | -1,518.2% | -664.8% | -272.0% | -85.3% | -49.8% | -17.9% | -85.6% | -447.0% | -564.3% | -64,169.6% | -58,477.3% | -71.7% | -91.0% | -33.0% | -0.6% | -215.2% | -152.2% | -147.5% | -398.7% | -165.7% | -12,405.6% | -283.3% | -272.2% | – | 94.1% | 94.0% | 94.0% | 93.4% | -347.1% | -229.4% | – | – | – | – | |
| -6,423.0% | -8,678.2% | -19,178.5% | -44,714.3% | -53,357.3% | -17,416.5% | -1,981.2% | -884.1% | -395.9% | -159.4% | -132.6% | -102.5% | -204.1% | -755.9% | -1,256.1% | -98,534.8% | -91,227.3% | -184.8% | -128.3% | -134.5% | -83.9% | -540.9% | -475.5% | -462.7% | -1,353.1% | -1,116.9% | -130,477.8% | -152,550.0% | -150,766.7% | – | -2,370.2% | -2,306.5% | -2,421.3% | -2,377.6% | -147,388.2% | -150,717.6% | -175,382.4% | – | -8.3% | -25.1% | |
| -1,882.1% | -2,579.2% | -5,805.6% | -13,635.3% | -16,544.8% | -5,547.8% | -639.8% | -292.3% | -136.7% | -63.6% | -63.0% | -65.0% | -133.8% | -471.9% | -843.5% | -69,995.7% | -63,745.5% | -132.5% | -108.4% | -71.0% | -46.3% | -324.3% | -313.9% | -364.6% | -1,063.9% | -949.7% | -92,533.3% | -106,244.4% | -119,538.9% | – | -2,061.6% | -2,036.0% | -1,847.2% | -1,815.3% | -109,935.3% | -115,029.4% | -138,058.8% | – | 6.1% | -12.9% | |
| -5,584.2% | -7,631.4% | -17,269.4% | -42,632.8% | -52,147.9% | -15,332.3% | -1,555.2% | -686.6% | -332.2% | -216.0% | -238.4% | -216.8% | -316.1% | -853.4% | -1,280.3% | -99,978.3% | -101,063.6% | -280.6% | -239.9% | -228.9% | -136.8% | -460.0% | -281.8% | -188.5% | -733.6% | -756.5% | -107,844.4% | -145,911.1% | -128,038.9% | – | -2,125.0% | -2,201.0% | -2,360.8% | -2,488.4% | -139,170.6% | -129,558.8% | -122,523.5% | – | -28.3% | -45.5% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.1% | -122.5% | -122.0% | -151.3% | -236.0% | -708.0% | -33.3% | -41.9% | 2.5% | -6.0% | |
| -28.3% | -30.0% | -34.6% | -45.4% | -66.0% | -57.8% | -101.0% | -124.6% | -100.4% | -92.4% | -66.3% | -76.3% | -106.7% | -140.8% | -211.3% | -151.5% | -199.0% | -57.5% | -47.8% | -24.3% | -15.3% | -51.0% | -78.0% | -49.5% | -60.5% | -57.7% | -57.8% | -85.3% | -144.2% | -183.8% | -38.0% | -43.4% | -42.4% | -48.2% | -58.4% | -73.9% | -23.6% | -30.0% | 2.3% | -5.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -40 | -32 | -15 | -13 | -1.2 | 7.8 | 13 | 18 | 14 | 14 | 8.5 | 9.7 | 6.6 | 4.5 | 4.1 | -1.7 | 0.7 | -5.5 | -8.3 | -11 | -19 | -13 | -12 | -18 | -15 | -12 | -19 | -12 | -7.6 | -9.1 | -52 | -45 | -41 | -37 | -31 | -26 | -98 | – | – | – | |
| -203.3% | -166.9% | -255.5% | -297.4% | -566.6% | -541.1% | -1,010.2% | -637.8% | -396.6% | -968.0% | -537.8% | -550.1% | -516.9% | -529.1% | -836.7% | -654.2% | -729.1% | -541.6% | -335.9% | -220.8% | -68.5% | -38.2% | -40.1% | -23.1% | -46.7% | -32.3% | -66.6% | -112.7% | -169.1% | -224.0% | 38.4% | 35.5% | 34.8% | 31.9% | 24.7% | 10.4% | 70.9% | 71.7% | 91.0% | 89.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -1.60 | -1.69 | -1.72 | -66.96 | -65.54 | -66.62 | -61.35 | -55.66 | -36.18 | -17.89 | -12.45 | -9.88 | -12.12 | -13.75 | -14.37 | -13.35 | -11.63 | -7.13 | -5.68 | -3.59 | -3.15 | -7.78 | -9.41 | -10.40 | -10.67 | -9.41 | -8.18 | -9.39 | -10.56 | -9.71 | -4.98 | -3.15 | -3.36 | -3.20 | -2.84 | -2.97 | -2.91 | -3.20 | 0.27 | -0.38 | |
| 0.08 | 0.07 | 0.03 | 0.49 | 0.40 | 1.20 | 9.59 | 19.05 | 26.47 | 28.11 | 19.75 | 15.19 | 9.06 | 2.91 | 1.70 | 0.02 | 0.02 | 5.38 | 5.24 | 5.05 | 6.81 | 2.40 | 3.00 | 2.85 | 1.00 | 0.99 | 0.01 | 0.01 | 0.01 | 0.00 | 0.24 | 0.15 | 0.18 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 4.37 | 2.97 | |
| -11.48 | -9.38 | -12.74 | -439.11 | -562.47 | -623.31 | -613.58 | -284.97 | -142.95 | -187.32 | -101.01 | -71.19 | -58.70 | -51.66 | -56.90 | -57.65 | -42.60 | -67.19 | -39.86 | -32.64 | -14.11 | -5.83 | -4.84 | -4.85 | -8.23 | -5.27 | -9.42 | -12.41 | -12.39 | -11.84 | 5.02 | 2.57 | 2.75 | 2.11 | 1.20 | 0.42 | 8.76 | 7.65 | 10.68 | 6.34 | |
| -4.74 | -4.99 | -5.13 | -209.35 | -206.59 | -184.12 | -149.11 | -130.76 | -87.96 | -60.73 | -47.09 | -32.93 | -28.65 | -24.86 | -21.81 | -19.07 | -18.44 | -15.10 | -12.56 | -11.56 | -9.31 | -11.03 | -8.45 | -5.38 | -7.36 | -7.49 | -9.53 | -12.89 | -11.31 | -9.15 | -5.13 | -3.41 | -4.29 | -4.39 | -3.59 | -3.34 | -2.59 | -3.00 | -1.24 | -1.35 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.